ARCHIVES

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

This article is from The Cancer Letter archive.

Vol. 08 No. 21 | May 21, 1982

Download PDF Visit The Full Archive

Related Articles

ASCO Weighs In On Tobacco Debate

September 19, 1997

Nomograms 66% Correct In Predicting Outcome For Brachytherapy, Study Finds

September 28, 2001

Amgen, Genzyme, Thoratec Mourn Loss Of Executives Killed In Plane Hijackings.

September 21, 2001

Device Shortens Time To Make T Cells For Immunotherapy

March 27, 2009

Bioassay Backlog To Be Cleared Up In Year: Squire

November 26, 1976

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011